Vivotif typhoid oral
Selected indexed studies
- Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. (J Travel Med, 1998) [PMID:9772307]
- Typhoid Vaccine. (, 2006) [PMID:30000191]
- Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®). (J Prev Med Hyg, 2017) [PMID:28515625]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. (1998) pubmed
- Typhoid Vaccine. (2006) pubmed
- Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®). (2017) pubmed
- A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif). (2017) pubmed
- Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. (1998) pubmed
- Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines. (2018) pubmed
- Vaccination of active component US military personnel against Salmonella Typhi. (2017) pubmed
- Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens. (2007) pubmed
- CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. (2007) pubmed
- Evaluating and optimizing oral formulations of live bacterial vaccines using a gastro-small intestine model. (2016) pubmed